Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Metadata
Title
Evaluation of the Vitek 2 System for Susceptibility Testing of Streptococcus pneumoniae Isolates
Publication date
01-09-2000
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2000
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s100960000332

Other articles of this Issue 8/2000

European Journal of Clinical Microbiology & Infectious Diseases 8/2000 Go to the issue

Brief Reports

Molecular Analyses of Possible Mechanisms Coding for Low-Level Mupirocin Resistance in Clinical Staphylococcus aureus Isolates

Brief Reports

Oral Leishmaniasis in an HIV-Infected Patient

Article

Determinants for the Development of Oropharyngeal Colonization or Infection by Fluconazole-Resistant Candida Strains in HIV-Infected Patients

Brief Reports

Mixed Community-Acquired Fungal Infection in an Apparently Healthy Patient

Article

In Vitro Zones of Inhibition of Coated Vascular Catheters Predict Efficacy in Preventing Catheter Infection with Staphylococcus aureus In Vivo

Brief Reports

In Vitro Activity of a New Liposomal Nystatin Formulation Against Opportunistic Fungal Pathogens

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits